No. 2(68) (2023): Oncology and Radiology of Kazakhstan

View No. 2(68) (2023): Oncology and Radiology of Kazakhstan
Published: 08.07.2023

Full Issue

Статьи

  • Developing and implementing the quality control program on a linear accelerator

    T.Yu. Antropova, K.D. Datbayev, Y. I. Ishkinin, B.G. Latypova, O.K. Seitov, Zh.T. Khudaibergenov
    4-8
    DOI: https://doi.org/10.52532/2521-6414-2023-2-68-4-8

  • Cervical cancer incidence and mortality in Almaty in 2005-2022

    N.A. Izbagambetov, D.R. Kaidarova, R.O. Bolatbekova, A.S. Shinbolatova, T.E. Valieva, A.E. Aidarov, G.B. Bagatova, A.I. Sarmenova , D.B. Zhaksylykova, A.S. Akkasova, A.A. Yestaeva, A.R. Satanova
    9-14
    DOI: https://doi.org/10.52532/2521-6414-2023-2-68-9-14

  • Optimization of molecular genetic diagnostics of patients with advanced non-small cell lung cancer by introducing ROS1 testing in the Republic of Kazakhstan

    O.V. Shatkovskaya, D.R. Kaidarova, M.G. Orazgaliyeva, E.B. Satbayeva, S.O. Ossikbayeva, A.B. Koishibaeva
    15-21
    DOI: https://doi.org/10.52532/2521-6414-2023-2-68-15-21

  • DNA double-stranded breaks and repairs in acute leukemia

    M.G. Bulegenova, A. Dunayeva, S.S. Saliyeva, A.A. Uskenbayeva
    22-27
    DOI: https://doi.org/10.52532/2521-6414-2023-2-68-22-27

  • Quantification of DNA double-strand breaks in benign and malignant breast diseases

    G.A. Smagulova, M.A. Aitmagambetova, G.V. Veklenko, N.M. Kereeva, A.N. Zheksenova, А. Amanzholkyzy, A.B. Tulyaeva, G.B. Bakytzhanov
    28-35
    DOI: https://doi.org/10.52532/2521-6414-2023-2-68-28-35

  • DWI capacity in prostate cancer diagnosing

    K.E. Karakoishin, Zh.Zh. Zholdybay, A.S. Aynakulova, D.K. Toleshbaev, G.M. Muhit, Ye. Ayserbay
    36-42
    DOI: https://doi.org/10.52532/2521-6414-2023-2-68-36-42

  • The role of clinical-hematological and cytogenetic characteristics in the program therapy of b-cell leukemia in children in the Republic of Kazakhstan

    L.N. Manzhuova, G.T. Tashenova, A.B. Tulebayeva, E.S. Sarsekbaev , A.S. Zhailaubaeva , G.E. Omarova , D.M. Yeginbergenova
    43-52
    DOI: https://doi.org/10.52532/2521-6414-2023-2-68-43-52

  • Evaluation of the effectiveness of neoadjuvant chemotherapy in breast cancer

    A.T. Omar, N.A. Kabildina, E.V. Kruk, A.M. Telmanov , Zh.K. Kabildin
    53-58
    DOI: https://doi.org/10.52532/2521-6414-2023-2-68-53-58

  • Endocrine toxicity of immune checkpoint inhibitors in clinical practice

    S.Z. Safina , G.K. Mukhamed’yarova, V.V. Dimitrieva
    59-63
    DOI: https://doi.org/10.52532/2521-6414-2023-2-68-59-63

  • The prospects and challenges of CRISPR/Cas9 gene editing in cancer therapy: A literature review

    D.A. Abdussadyk, A.Zh. Beisenova
    64-68
    DOI: https://doi.org/10.52532/2521-6414-2023-2-68-64-68

  • International experience in applying the system of pediatric early warning signs of critical conditions in oncological children: A literature review

    E.B. Kurakbayev, B.S. Turdaliyeva, L.N. Manzhuova, К.О. Omarova, G.K. Abdilova, A.Z. Kusainov, S.S. Saparbayev, V.V. Shcukin
    69-75
    DOI: https://doi.org/10.52532/2521-6414-2023-2-68-69-75

  • Prognostic value of liquid biopsy in CRC: A literature review

    T.S. Nasrytdinov
    76-81
    DOI: https://doi.org/10.52532/2521-6414-2023-2-68-76-81